These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21753730)

  • 21. Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl.
    Gilbert PB; Hudgens MG; Wolfson J
    Int J Biostat; 2011; 7(1):Article 36. PubMed ID: 22049267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines.
    Alsallaq RA; Gurarie D; Ndeffo Mbah M; Galvani A; King C
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005544. PubMed ID: 28410369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.
    Pisu M; Meltzer MI; Hurwitz ES; Haber M
    Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A stochastic model of vaccine trials for endemic infections using group randomization.
    Riggs TW; Koopman JS
    Epidemiol Infect; 2004 Oct; 132(5):927-38. PubMed ID: 15473157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine impact in homogeneous and age-structured models.
    Magpantay FMG
    J Math Biol; 2017 Dec; 75(6-7):1591-1617. PubMed ID: 28417166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field.
    Halloran ME; Longini IM; Haber MJ; Struchiner CJ; Brunet RC
    Stat Med; 1994 Feb; 13(4):357-77. PubMed ID: 8177986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts.
    Hurwitz ES; Haber M; Chang A; Shope T; Teo S; Ginsberg M; Waecker N; Cox NJ
    JAMA; 2000 Oct; 284(13):1677-82. PubMed ID: 11015798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A principal stratification approach for evaluating natural direct and indirect effects in the presence of treatment-induced intermediate confounding.
    Taguri M; Chiba Y
    Stat Med; 2015 Jan; 34(1):131-44. PubMed ID: 25312003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
    Patel M; Lee CK
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001093. PubMed ID: 15674874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximizing statistical power in group-randomized vaccine trials.
    Riggs T; Koopman JS
    Epidemiol Infect; 2005 Dec; 133(6):993-1008. PubMed ID: 16274496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How is vaccine effectiveness scaled by the transmission dynamics of interacting pathogen strains with cross-protective immunity?
    Omori R; Cowling BJ; Nishiura H
    PLoS One; 2012; 7(11):e50751. PubMed ID: 23226374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unified evaluation of differential vaccine efficacy.
    Gabriel EE; Sachs MC; Follmann DA; Andersson TM
    Biometrics; 2020 Dec; 76(4):1053-1063. PubMed ID: 31868914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of vaccination on the infectious diseases epidemiology: example of pertussis].
    Guiso N
    Med Sci (Paris); 2007 Apr; 23(4):399-403. PubMed ID: 17433230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
    Chiba Y
    Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.
    Longini IM; Sagatelian K; Rida WN; Halloran ME
    Stat Med; 1998 May; 17(10):1121-36. PubMed ID: 9618773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household.
    Datta S; Halloran ME; Longini IM
    Biometrics; 1999 Sep; 55(3):792-8. PubMed ID: 11315008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.